gorab Antibody

What is the optimal dilution range for GORAB antibodies in various applications?

GORAB antibodies require specific dilution optimization depending on both the application and the specific antibody source. Based on compiled data from multiple manufacturers, the following ranges are recommended:

For optimal results, always perform a dilution series experiment with your specific sample type. For instance, the anti-GORAB antibody from Proteintech (17798-1-AP) shows best results at 1:1000-1:5000 for Western blotting, while the St John's Laboratory antibody (STJ96734) performs best at 1:500-1:2000 for the same application .

How can I validate the specificity of my GORAB antibody?

Validation of GORAB antibodies should follow a multi-step approach:

• Positive controls: Use cell lines known to express GORAB (HeLa, HEK-293, K-562 cells, and mouse lung tissue are well-documented positive samples) .

• Knockout/knockdown validation: Compare antibody signals between wild-type samples and GORAB knockout or knockdown samples. This is considered the gold standard for antibody validation . Multiple studies have used GORAB-null mutant flies or GORAB-knockdown MEFs to confirm antibody specificity .

• Recombinant protein detection: Test the antibody against recombinant GORAB protein alongside endogenous samples.

• Multiple epitope targeting: Use antibodies targeting different regions of GORAB to confirm consistent results. Available options include:

  • N-terminal region (amino acids 1-50)

  • Internal/coiled-coil regions (amino acids 201-300)

  • C-terminal region (amino acids 315-364)

• Cross-reactivity assessment: Examine reactivity with related golgins using protein arrays. High-quality antibodies have been tested against arrays of 364 human recombinant protein fragments .

What molecular weight should I expect when detecting GORAB by Western blot?

GORAB protein detection by Western blot can be complex due to multiple isoforms and post-translational modifications:

When running Western blots for GORAB, include positive control lysates from HEK-293 or HeLa cells. The apparent molecular weight discrepancy between calculated and observed values likely results from post-translational modifications common in Golgi proteins .

What fixation and permeabilization methods are optimal for GORAB immunostaining?

For successful immunolocalization of GORAB, proper fixation and permeabilization are critical:

For optimal visualization of GORAB's dual localization, consider dual immunostaining with markers for:

• Trans-Golgi: Golgin245, TGN46

• Centrioles: dPLP, Centrosomin (Cnn), Asterless (Asl)

When studying cells undergoing mitosis, take note that Golgi components become dispersed throughout the cell, while a fraction of GORAB remains stably associated with the centrosome .

How can I select the appropriate GORAB antibody for my specific research question?

Selection of the optimal GORAB antibody depends on your specific research focus:

For the most comprehensive analysis, consider using multiple antibodies targeting different epitopes in parallel experiments to confirm your findings.

How can I design experiments to distinguish between GORAB's Golgi and centriole functions?

To separate GORAB's dual functions, implement these research strategies:

• Mutant rescue experiments:

  • Create GORAB variants that cannot localize to trans-Golgi but maintain centriole function

  • Research from Kovacs et al. demonstrated that specific mutations in GORAB can rescue centriole and cilia defects of gorab null flies without affecting Golgi functions

• Domain-specific targeting:

  • Target the SID domain (aa 260-286) to disrupt Sas6 interaction without affecting Golgi functions

  • Target the IGRAB domain (aa 99-277) to disrupt Golgi functions while maintaining centriole interactions

• Temporal analysis:

  • Study GORAB during mitosis when Golgi components disperse but centriolar GORAB remains stable

  • Use live cell imaging with fluorescent GORAB constructs to track localization dynamics

• Subcellular fractionation:

  • Separate Golgi and centrosomal fractions to quantify GORAB distribution

  • Analyze interaction partners specific to each fraction using co-immunoprecipitation

• Tissue-specific analysis:

  • Study tissues where one function predominates (e.g., ciliated tissues for centriole function)

  • Research shows gorab null flies display coordination defects due to sensory cilia defects, which can be rescued by nervous system-specific expression of GORAB

What experimental approaches can effectively probe GORAB's interactions with Sas6 in centriole duplication?

To investigate GORAB-Sas6 interactions in centriole duplication:

• In vitro binding assays:

  • Use purified components to demonstrate direct binding

  • Pull-down assays with GST-Sas6 and MBP-Gorab have confirmed direct interaction

  • Identify the SID (Sas6 Interaction Domain) within GORAB (residues 260-286 in Drosophila)

• Co-immunoprecipitation:

  • Express tagged versions (myc-Sas6 and GFP-Gorab) in cells

  • Perform GFP pull-downs to detect interaction

  • Compare wild-type GORAB with GORAB ΔSID to confirm specificity

• Proximity ligation assays:

  • Detect in situ interaction between endogenous proteins

  • Quantify interaction signals in different cell cycle stages

• Structural studies:

  • Investigate how GORAB dimerization affects Sas6 binding

  • Research shows GORAB binds to Sas6 as a monomer, indicating dimerization regulation

• Functional assays:

  • Analyze centriole duplication efficiency in cells expressing wild-type vs. ΔSID GORAB

  • Quantify centrobin staining of basal bodies as a measure of centriole duplication

What controls are essential when investigating GORAB mutant phenotypes in disease models?

When studying GORAB mutations and their phenotypic consequences:

• Genotyping controls:

  • Confirm mutations using both genomic DNA sequencing and expression analysis

  • Researchers have verified GORAB null mutants using direct genomic DNA sequencing and Western blotting with polyclonal antibodies

• Rescue experiments:

  • Express wild-type GORAB to confirm phenotype reversibility

  • Use tissue-specific expression systems (e.g., elav-GAL4 for neural expression)

  • Test domain-specific mutants to dissect function (e.g., GORAB without Golgi-targeting capability)

• Pathway analysis controls:

  • Include parallel analysis of known pathway components

  • For Hedgehog pathway studies, examine GLI3 processing and responsiveness to pathway activators like SAG

  • Monitor multiple downstream targets (e.g., both Gli1 and Ptch1 expression)

• Cellular phenotype controls:

  • Quantify cellular defects with appropriate markers

  • For centriole/ciliary phenotypes, examine multiple markers (Centrobin, Asl, Cnn)

  • For Golgi phenotypes, examine multiple Golgi markers (GM130, Golgin245)

• Temporal controls:

  • Analyze phenotypes at multiple developmental timepoints

  • Compare embryonic (E15.5, E18.5) vs. postnatal phenotypes in appropriate models

How can I optimize protocols for studying GORAB dimerization and its functional significance?

To investigate GORAB dimerization:

• Biochemical approaches:

  • Use non-denaturing gel electrophoresis to detect dimer formation

  • Apply chemical crosslinking followed by SDS-PAGE to stabilize dimers

  • Perform size exclusion chromatography to separate monomeric and dimeric forms

• Structural mutation analysis:

  • Create specific deletions in the predicted coiled-coil region (approximately aa 190-320)

  • Research shows deletion of residues 282-286 can disrupt dimerization

  • Express these constructs and analyze their localization in primary cells (e.g., spermatocytes and larval imaginal discs)

• Functional analysis:

  • Compare wild-type GORAB with dimerization-deficient mutants

  • Analyze both Golgi structure/function and centriole duplication

  • Examine interaction with binding partners (Sas6, Arf5, Rab6)

• Live cell imaging:

  • Use FRET-based approaches to monitor dimerization in vivo

  • Apply split-fluorescent protein complementation assays to visualize dimerization

• Cross-species comparison:

  • Analyze conservation of dimerization interfaces between human and Drosophila GORAB

  • Compare functional consequences of dimerization disruption across species

What methodological approaches can reveal GORAB's role in COPI trafficking at the trans-Golgi?

To investigate GORAB's function in COPI trafficking:

• Localization studies:

  • Use super-resolution microscopy to precisely map GORAB distribution

  • Research shows GORAB forms discrete puncta at the trans-Golgi rather than even distribution

  • Apply immuno-electron microscopy to visualize GORAB at the ultrastructural level

• Protein-protein interaction analysis:

  • Identify COPI components that interact with GORAB

  • Use proximity labeling techniques (BioID, APEX) to map the GORAB interactome

  • Confirm interactions through co-immunoprecipitation and GST pull-down assays

• Trafficking assays:

  • Monitor recycling of trans-Golgi enzymes in GORAB-deficient cells

  • Analyze glycosylation patterns of cargo proteins to assess functional consequences

  • Research shows GORAB loss results in improper glycosylation in both cultured cells and skin tissue

• Dynamic studies:

  • Use FRAP (Fluorescence Recovery After Photobleaching) to measure GORAB mobility

  • Apply live cell imaging to track COPI vesicle formation at GORAB-positive domains

• Structural organization analysis:

  • Investigate how GORAB forms stable membrane domains at the trans-Golgi

  • Study how these domains, via interaction with Scyl1, stabilize COPI assembly

How can I develop effective GORAB knockout/knockdown models to study its tissue-specific functions?

For generating and validating GORAB depletion models:

• CRISPR/Cas9 knockout strategies:

  • Target multiple sites simultaneously for complete gene disruption

  • Successful approaches have targeted 5' and 3' ends and exon 1 of the gorab gene

  • Confirm knockout by genomic PCR, sequencing, and Western blotting

• siRNA/shRNA knockdown optimization:

  • Test multiple siRNA sequences targeting different regions of GORAB mRNA

  • Validate knockdown efficiency in mouse embryonic fibroblasts (MEFs)

  • Monitor both mRNA levels (qRT-PCR) and protein levels (Western blot)

• Tissue-specific knockout models:

  • Utilize Cre-loxP systems for conditional knockouts in specific tissues

  • For neural-specific studies, use drivers like elav-GAL4

  • For skin studies, use keratinocyte-specific promoters

• Phenotypic validation:

  • Examine established GORAB-dependent processes:

    • Centriole duplication in mitotic cells (antibodies against Cnn or Asl)

    • Cilia formation in sensory organs (coordination tests in flies)

    • Hair follicle development (KRT17 immunofluorescence)

    • Hedgehog signaling (Gli1 and Ptch1 expression)

• Rescue experiments:

  • Reintroduce wild-type or mutant GORAB to validate phenotype specificity

  • Use inducible expression systems to control timing and level of rescue

What approaches can detect GORAB in clinical samples from patients with gerodermia osteodysplastica?

For clinical sample analysis of GORAB in disease contexts:

• Immunohistochemistry optimization:

  • For skin biopsies, use 1:500-1:1000 dilutions of validated antibodies

  • Compare with age-matched control samples

  • Counterstain with markers for Golgi (GM130, TGN46) and centrosomes to assess localization changes

• Western blot analysis:

  • Extract proteins from patient-derived fibroblasts

  • Use 0.04-0.4 μg/ml antibody concentration for optimal detection

  • Analyze both expression levels and potential molecular weight shifts

• Mutation-specific considerations:

  • For missense mutations, assess protein localization patterns

  • For truncation mutations, select antibodies targeting epitopes upstream of the mutation

  • Research shows GORAB missense mutations can disrupt RAB6 and ARF5 binding and Golgi targeting

• Functional readouts:

  • Assess COPI trafficking in patient-derived cells

  • Analyze glycosylation patterns of secreted proteins

  • Evaluate centriole duplication and cilia formation

• Comparative analysis:

  • Implement standardized protocols across multiple clinical samples

  • Correlate molecular findings with clinical severity

  • Compare effects of different mutations on GORAB's dual functions